Head-to-head · Cost-Efficiency Index
Teleios Health vs Blis MD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Teleios Health
Shoppers comfortable calling or messaging before committing, since public pricing detail is minimal.
Visit Teleios HealthBlis MD
Shoppers who want the lowest flat, dose-independent price found in this batch and don't need pharmacy/state transparency upfront.
Visit Blis MDThe verdict
Teleios Health takes it, leading the Cost-Efficiency Index 65 to 64. Teleios Health markets itself as a physician-led GLP-1 telehealth provider offering both compounded semaglutide and tirzepatide. Blis MD still earns a C — Shoppers who want the lowest flat, dose-independent price found in this batch and don't need pharmacy/state transparency upfront.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Teleios Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Teleios Health | Blis MD |
|---|---|---|
| Cost-Efficiency Index | 65/100 | 64/100 |
| Semaglutide / mo | $99/mo (all doses, compounded) | $109/mo (compounded) |
| Tirzepatide / mo | Not disclosed | $159/mo (compounded) |
| Semaglutide / yr (modeled) | $1,188 | $1,308 |
| Tirzepatide / yr (modeled) | — | $1,908 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #170 | #174 |
Teleios Health
65/100Where the value is
- Advertises a low $99/mo headline starting price, undercutting most compounded-GLP-1 competitors on paper
- Explicitly brands itself as 'physician-led,' setting an expectation of clinician oversight
- Discloses the standard compounded-medication FDA disclaimer up front rather than burying it
The tradeoffs
- No dose amount, drug, or inclusion breakdown is published for the $99/mo figure
- No visit fee, membership fee, or shipping fee disclosure could be found anywhere on the site
Blis MD
64/100Where the value is
- Genuinely low flat pricing — $109/mo semaglutide and $159/mo tirzepatide, both below most peers researched here
- Free initial consultation with a licensed provider
- Flat pricing regardless of dose tier (no escalation disclosed)
The tradeoffs
- No compounding pharmacy named anywhere on the site
- No named medical director or prescriber found
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.